Olmo, FranciscoCostas, MiquelMarin, ClotildeRosales, Maria JoseMartin-Escolano, RubenCusso, OlafGutierrez-Sanchez, RamonRibas, XaviSanchez-Moreno, Manuel2023-01-252023-01-252016-06-02Olmo F, Costas M, Marín C, Rosales MJ, Martín-Escolano R, Cussó O, et al. Tetradentate polyamines as efficient metallodrugs for Chagas disease treatment in murine model. J Chemother. 2017 Apr;29(2):83-93.http://hdl.handle.net/10668/10143A series of tetraamine-based compounds was prepared, and their trypanocidal effects against Trypanosoma cruzi and cytotoxicity were determined through the determination of IC50 values. In vivo assays were performed in mice, where parasitaemia levels were quantified by fresh blood examination and the assignment of a cure was determined by polymerase chain reaction and reactivation of blood parasitaemia levels after immunosuppression. The mechanisms of action were elucidated at metabolic and ultra-structural levels, by 1H NMR, Fe-SOD inhibition and TEM studies. The high-selectivity indexes observed in vitro were the basis of promoting one of the tested compounds to in vivo assays. Compound 6 induced a remarkable decrease in the reactivation of parasitaemia after immunosuppression and curative rates of 33%. The experiments allowed us to select compound 6 as a promising candidate for treating Chagas disease, but a further high-level study should be considered to obtain an improved efficiency.enAmerican trypanosomiasisChemotherapyMurine modelTetradentate polyaminesAnimalsChagas DiseaseDisease Models, AnimalFemaleMiceMice, Inbred BALB COrganometallic CompoundsPolyaminesTrypanosoma cruziresearch article27251893Restricted AccessAnimalesCompuestos organometálicosEnfermedad de chagasFemeninoModelos animales de enfermedadPoliaminasRatonesRatones endogámicos BALB CTrypanosoma cruzi10.1080/1120009X.2016.11905361973-9478https://researchonline.lshtm.ac.uk/id/eprint/2910302/6/Reviewed_Manuscript_JofC%20%28002%29.pdf